Earnings History Data for Heat Biologics (HTBX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Heat Biologics

Heat Biologics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. The Company's products under development include HS-110 for the treatment of non-small cell lung cancer, HS-410 for the bladder cancer treatment, HS-310 to treat ovarian cancer and HS-510 for treating triple negative breast cancer. Heat Biologics, Inc. is based in Chapel Hill, North Carolina.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
10-11-2021 AH HTBX Heat Biologics 134.00 -0.30 -0.29 0.00 Heat Biologics EPS in-line, beats on revenue
[11/10/2021 4:33 PM]
5.23 0.07 
5.10 -0.06 
4.90 - 17.00 449,227 250,000 4,915
11-08-2021 AH After the close
(Aug 11)
HTBX Heat Biologics, Inc. 169.00 -0.26 -0.28 0.00 Heat Biologics EPS beats by $0.05, misses on revenue
[8/11/2021 4:32 PM]
6.66 0.03 
6.66 0.03 
5.22 - 17.00 156,664 200,000 1,806
05-05-2021 PM HTBX Heat Biologics, Inc. 183.00 -0.31 -0.29 0.00 Heat Biologics EPS misses by $0.01, misses on revenue
[5/5/2021 7:58 AM]
6.67 -0.07 
7.00 0.26 
3.62 - 30.10 316,448 300,000 4,732